The cost of Quviviq (daridorexant) in Canada can vary depending on factors such as the pharmacy, insurance coverage, and the specific dosage prescribed. As of early 2024, a 30-day supply of Quviviq can range from approximately $300 to over $400 CAD [1].
What is Quviviq used for?
Quviviq is a medication prescribed to treat adults with insomnia disorder. It works by blocking orexin receptors in the brain, which are responsible for promoting wakefulness. By doing so, it helps individuals fall asleep and stay asleep [2].
How does Quviviq work to treat insomnia?
Insomnia is often associated with an overactive wakefulness system in the brain, driven by neurotransmitters like orexin. Quviviq, a dual orexin receptor antagonist, inhibits the action of these wakefulness-promoting pathways. This mechanism helps to reduce the drive for wakefulness, facilitating sleep onset and maintenance [2].
What are the different dosages of Quviviq available in Canada?
Quviviq is typically available in two strengths: 25 mg and 50 mg [2]. The appropriate dosage is determined by a healthcare professional based on the individual's needs and response to the medication.
What is the typical prescription duration for Quviviq?
Prescriptions for Quviviq are generally for a 30-day supply. Patients are advised to follow their doctor's instructions regarding the duration of treatment, as it is intended for short-term use in managing insomnia disorder [1, 2].
Are there patient assistance programs for Quviviq in Canada?
Information regarding specific patient assistance programs for Quviviq in Canada may be available through the manufacturer or by consulting with a healthcare provider. These programs can sometimes help reduce out-of-pocket costs for eligible patients [1].
How does Quviviq's cost compare to other insomnia treatments in Canada?
The cost of Quviviq is comparable to other prescription medications used for insomnia. For example, other prescription sleep aids can also incur significant out-of-pocket expenses, especially without comprehensive insurance coverage. Factors influencing the overall cost include the drug's mechanism of action, efficacy, and the prevalence of its use [1].
When did Quviviq become available in Canada?
Quviviq received Health Canada approval in January 2022, making it available to Canadian patients for the treatment of insomnia disorder shortly thereafter [3].
What are the potential side effects of Quviviq?
Common side effects reported with Quviviq include sleep paralysis, vivid dreams, and headache. Less common but more serious side effects may also occur. Patients should discuss any concerns about side effects with their prescribing physician [2].
Where can I find more information on Quviviq pricing and coverage in Canada?
For the most current and detailed information on Quviviq pricing, potential coverage options, and any available assistance programs in Canada, it is recommended to consult with your local pharmacy, your healthcare provider, or refer to drug information resources. Websites such as DrugPatentWatch.com can provide insights into patent information and drug availability, which can indirectly influence pricing and market dynamics [1].
---
Sources:
[1] DrugPatentWatch.com
[2] Quviviq prescribing information
[3] Health Canada Drug and Health Product Information